Epigenetic reader domain inhibitor BAY-299, Purity ≥98%

Cat. No.: X24-05-ZQ418

Epigenetic reader domain inhibitor BAY-299, Purity ≥98%

Synonym: 2080306-23-4; BAY 299; BAY299; Epigenetic reader domain inhibitor

  • CAS Number: 2080306-23-4
  • Compound CID: 122705990
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
BAY-299 disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals. It targets BRPF1 BD, BRPF2 BD, BRPF3 BD, BRPF1 BD, and TAF1L BD2.
Molecular Weight
429.47
Molecular Formula
C25H23N3O4
Targets
BRPF1 BD: 3150 nM; BRPF2 BD: 67 nM; BRPF3 BD: 5550 nM; BRPF1 BD: 8 nM; TAF1L BD2: 106 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
BAY-299 can be utilized to explore the inhibition of BRD4, a key BET bromodomain protein, in relation to gene transcription and cancer.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0